should i take tirzepatide morning or night when to Best time shot: the complete timing guide take tirzepatide in – Best Time of Day To

Trial 1: 13-Week Injectable VK2735 Study Significant Weight Loss Observed The first of Vikings recent trials focused on an injectable form of VK2735 over a 13-week period

Tirzepatide is a dual-agonist, targeting both GLP-1 and GIP receptors, whereas semaglutide is a single-agonist that targets only GLP-1

Mast cell activation and histamine release Mast cells are the primary drivers of injection site itching and redness

This phenomenon occurs through several metabolic mechanisms: Increased breakdown of purines : When the body metabolises fat and muscle tissue during weight loss, purines (compounds found in body tissues) are broken down, producing uric acid as a by-product Ketone body production : Rapid weight loss, particularly with very low-calorie diets, leads to ketone production, which competes with uric acid for excretion by the kidneys Reduced renal clearance : Ketones and other metabolic by-products can temporarily impair the kidneys' ability to excrete uric acid efficiently Dehydration : Weight loss programmes may involve reduced fluid intake or increased fluid loss, concentrating uric acid in the blood The rate of weight loss appears to be a critical factor

Harvard Francisco de Souza, Hugo